Mankind Pharma and Innovent Collaborate to Improve Cancer Care Access in India
Mankind Pharma has announced a strategic partnership with Innovent Biologics to introduce Sintilimab, a PD-1 immunotherapy, to the Indian market….
Read Global and Indian Healthcare Economics and Market news with TISHHA. Fastest coverage of all aspects related to industry deals, policies, plans, mergers and much more
Mankind Pharma has announced a strategic partnership with Innovent Biologics to introduce Sintilimab, a PD-1 immunotherapy, to the Indian market….
The annual report from the Insurance Regulatory and Development Authority of India (IRDAI) has raised concerns about the declining insurance…
Credit:- Sugandh Khandelwal India’s healthcare and pharmaceutical sectors raised ₹14,811 crore through initial public offerings (IPOs), marking the highest annual…
IKS Health (Inventurus Knowledge Solutions Ltd) , a leading provider of administrative solutions for healthcare organizations and backed by Rekha…
Credit:- Sugandh Khandelwal Manipal Health Enterprises has been successfully acquired by Temasek, which now holds a majority stake. Temasek now…
EQT Asia has exceeded its original investment target of $5 billion in India over the past few years, according to…
Suraksha Diagnostics’ stock opened at ₹437 and ₹438 on the BSE & NSE respectively, slipping 0.90% & 0.68% respectively below…
India is on track to solidify its position as a key player in the global medical technology (MedTech) market, with…
Dr. Lal Path Labs: In this comprehensive report on Dr. Lal Path Labs possibly expanding into Southern India in near…
New Delhi: The AYUSH sector has grown from USD 2.85 billion in 2014 to USD 43.4 billion in 2023, as…